Jump Financial »

Dianthus Therapeutics shares owned by Jump Financial

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Jump Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.4M 25k 97.48
2024-03-31 $418k 14k 30.00

More positions owned by Jump Financial

State Street SPDR S&P 500 ETF Trust Etf (SPY)
iShares Core S&P 500 ETF Etf (IVV)
Invesco QQQ Trust Series 1 Etf Call Option (QQQ)
Direxion Daily Semiconductor Bull 3X ETF Etf (SOXL)
iShares Russell 2000 ETF Etf Call Option (IWM)
Vanguard S&P 500 ETF Etf (VOO)
iShares iBoxx USD High Yield Corporate Bond ETF Etf Call Option (HYG)
Bloom Energy Corp Common Stock (BE)
Sandisk Corp Common Stock (SNDK)
iShares MSCI South Korea ETF Etf (EWY)
iShares 20 Year Treasury Bond ETF Etf Call Option (TLT)
Seagate Technology Holdings Common Stock (STX)
Super Micro Computer Convertible bond (Principal)
Western Digital Corp Common Stock (WDC)
Intel Corp Common Stock (INTC)

View all positions for Jump Financial

Top funds holding Dianthus Therapeutics

FMR
BlackRock
Wellington Management Company
Fairmount Funds Management
Vanguard Capital Management
Avidity Partners Management
Octagon Capital Advisors
TCG Crossover Management
State Street Corporation
Fred Alger Management
Geode Capital Management
VR Adviser
T. Rowe Price Associates
UBS Group
Deerfield Management Company

View all funds holding Dianthus Therapeutics